FIELD: pharmacology.
SUBSTANCE: invention relates to a new semi-synthetic derivative of glycopeptide eremomycine antibiotic, which is eremomycine tetramethylenimide of formula
, and its pharmaceutically acceptable salts. A method for production of eremomycine tetramethylenimide of formula 2, its pharmaceutical compositions and their use for treatment of mammalian infections caused by gram-positive bacteria, including insensitive or low-sensitive to other antibiotics.
EFFECT: compound efficiency increase.
6 cl, 4 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL DERIVATIVES OF EREMOMYCIN AND USE THEREOF FOR TREATING BACTERIAL INFECTIONS | 2019 |
|
RU2708628C1 |
METHOD FOR TREATMENT OF HUMAN DISEASES CAUSED BY GRAM-POSITIVE BACTERIA | 2017 |
|
RU2661613C1 |
N-(GUANIDINOALKYL) AMIDES OF EREMOMYCIN AND THEIR USE FOR TREATING BACTERIAL INFECTIONS | 2022 |
|
RU2815029C1 |
NEW DERIVATIVES OF EREMOMYCIN AMIDE AND APPLICATION THEREOF FOR TREATING BACTERIAL INFECTIONS | 2020 |
|
RU2751334C1 |
CHIMERIC ANTIBIOTICS BASED ON AZITHROMYCIN AND GLYCOPEPTIDE ANTIBIOTICS, HAVING ANTIBACTERIAL ACTIVITY AND SYNTHESIS METHOD THEREOF | 2014 |
|
RU2578604C1 |
CHIMERIC ANTIBIOTICS BASED ON GLYCOPEPTIDES AND 11,12-CYCLIC CARBONATE AZITHROMYCIN AND METHOD FOR PRODUCTION THEREOF | 2014 |
|
RU2570425C1 |
ANTIBIOTIC EREMOMYCIN AND METHOD OF ITS PREPARING | 1981 |
|
SU1475150A1 |
STRAIN AMYCOLATOPSIS ORIENTALIS SUBSPECIES EREMOMYCINI VKPM-S892 - A PRODUCER OF ANTIBIOTIC EREMOMYCIN AND A METHOD OF ANTIBIOTIC EREMOMYCIN PRODUCING | 1997 |
|
RU2110578C1 |
METHOD OF TREATMENT OF INFECTION CAUSED BY STRAINS OF GENUS STAPHYLOCOCCUS, STREPTOCOCCUS OR ENTEROCOCCUS WITH MULTIPLE DRUG RESISTANCE | 1996 |
|
RU2202360C2 |
ANTIBIOTIC INA 5812, STRAIN-PRODUCER Streptomyces roseoflavus INA-As-5812 AND METHOD FOR ANTIBIOTIC OBTAINING | 2013 |
|
RU2572341C2 |
Authors
Dates
2018-01-23—Published
2016-11-02—Filed